AGARWALEYE share price, P/E, ROE & financials

Dr. Agarwal's Health Care (AGARWALEYE) had a P/E of 111.0× on 6 Nov 2026, above the industry P/E of 28.6×. It earns ROCE of 9.7% and ROE of 9.7%, and sales and net profit grew 27% and 12% a year over 3 years. Debt is 0.53× equity. It is a small-cap company with a market cap of ₹16,371 Cr, ranked 2nd of 11 Medical Instruments & Supplies companies by market cap; the shares fell 0.7% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹510.00
Day high: ₹523.30
Day low: ₹492.50
Prev. close: ₹511.70
Volume: 2.1 L

Health check

1 good · 2 fair · 3 to check

ReturnsIn line
−0.7% over a year, better than 4 of 7 peers.
Price tagPricier
P/E 111.0 vs industry 28.6.
GrowthStrong
Sales +26.9%, profit +12.3% a year over 3 years.
ProfitabilityWeak
ROCE 9.7% vs peer median 13.3%.
Balance sheetFair
Debt 0.53× equity, interest covered 3.8×, Piotroski 7 of 9.
Red flags1 to check
P/E of 111.0 against an industry P/E of 28.6.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Instruments & Supplies

10 listed peers. Screen the industry

Small cap

₹16,371 Cr, #2 of 11 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹2,358 Cr · profit ₹170 Cr

Market cap: ₹16,371 Cr; Small cap
P/E: 111.0; Industry 28.6
Price to book: 7.66; Peers 4.44
Dividend yield: 0.00%
ROE: 9.7%; Peers 11.0%
ROCE: 9.7%; Peers 13.3%
Debt to equity: 0.53; Debt ₹1,182 Cr
EPS (TTM): ₹4.65; Face value ₹1
OPM (TTM): 15.5%; Net margin 7.2%
Sales growth: +26.0%; Latest quarter vs a year ago
Profit growth: +50.5%; Latest quarter vs a year ago
Price to sales: 6.94; EV/EBITDA 33.2

Strengths

Quarterly profit up 50.5% on a year ago.
Quarterly sales up 26.0% on a year ago.
Positive operating cash flow in each of the last 4 years.

Risks to check

P/E of 111.0 against an industry P/E of 28.6.

Derived automatically from reported figures. Not a recommendation.

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited engages in running, owning, and managing eye care hospitals, opticals, pharmacies, etc. and related services in India and internationally. It offers femto cataracts, lenticular procedure, retinal surgeries, anterior segment reconstruction, and corneal transplants, as well as refractive and other surgeries. The company also develops, designs, manufactures, imports, and exports healthcare devices, which include ophthalmic…

Headquarters: Chennai
Sector: Healthcare
ISIN: INE943P01029
Website: dragarwals.co.in

Price range

52 weeks

₹401.00₹567.75

Today

₹492.50₹523.30

Avg volume (3M): 11 L
1-year return: minus 0.7%
From 52-week high: minus 9.1%

Analyst consensus

5 analysts

No consensusMean target ₹584.60 13.2%

Target range, with today’s price

Low ₹555.00High ₹622.00

Today’s price ₹516.35 is below the lowest analyst target.

Consensus from Yahoo Finance. Not a recommendation.

Peers · Medical Instruments & Supplies

Compare with peers Screen the whole industry

Company
LENSKARTLenskart Solutions	724.75	plus 0.89%	1,25,562	160.7	13.48	7.2%	6.7%	20.8%	–	–	0.00%	plus 78.2%
AGARWALEYEDr. Agarwal's Health Care	516.35	plus 0.91%	16,371	111.0	7.66	9.7%	6.8%	15.0%	26.9%	12.3%	0.00%	minus 0.7%
POLYMEDPoly Medicure	1,612.30	plus 0.63%	16,343	51.4	5.26	13.3%	11.0%	15.2%	18.8%	21.6%	0.22%	minus 18.1%
TARSONSTarsons Products	316.95	minus 0.46%	1,686	151.7	2.64	4.8%	2.3%	−0.9%	14.3%	−43.8%	0.00%	plus 10.9%
LAXMIDENTLLaxmi Dental	196.42	minus 0.05%	1,081	34.8	4.44	11.5%	12.8%	16.4%	19.5%	–	0.00%	minus 37.9%
PREVESTPrevest Denpro	397.85	minus 3.85%	478	22.0	3.83	21.9%	17.8%	34.8%	12.4%	9.3%	0.24%	minus 21.2%
QMSMEDIQMS Medical Allied Services	168.66	minus 0.69%	326	28.6	5.68	18.4%	10.5%	12.0%	18.4%	16.7%	0.29%	plus 75.0%
SHREEPACShree Pacetronix	170.00	plus 0.32%	64	19.5	3.41	25.0%	19.7%	24.8%	2.2%	−1.2%	0.00%	minus 38.5%
Median of 7 peers	–	−0.05%	1,081	34.8	4.44	13.3%	11.0%	16.4%	16.4%	9.3%	0.00%	−18.1%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Mar 25	Jun 25	Dec 25	Mar 26	Jun 26
460	487	530	564	614
–	–	–	+22.6%	+26.0%
329	360	386	403	444
131	128	144	161	170
28.5%	26.2%	27.2%	28.6%	27.8%
15.4	13.4	10.5	12.6	6.4
25	24.7	21.1	22.1	23.4
60.4	63	68.8	76.7	78.3
−2.5	–	–	1.3	–
58.5	53.6	64.8	76.6	75.1
27.3%	29.0%	32.6%	34.8%	26.8%
32.6	30.1	33.7	39.7	45.2
–	–	–	+21.9%	+50.5%
1.03	0.95	1.06	1.24	1.42

Sep 25 not reported by the data source.

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: +26.9%
Profit CAGR 3Y: +12.3%
EPS CAGR 3Y: +12.0%
ROE: 9.7%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
1,016	1,328	1,705	2,077
–	+30.6%	+28.4%	+21.9%
735	955	1,225	1,494
282	372	479	583
27.7%	28.0%	28.1%	28.1%
1.8	14.2	11.7	21.8
72	95.6	108	90.3
128	170	231	276
0.2	20.2	7.4	10.2
83.6	141	160	249
−23.5%	32.4%	31.0%	32.4%
94.1	83.1	83.5	133
–	minus 11.7%	+0.5%	+59.6%
2.98	2.63	2.78	4.18

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
7.9	9.4	31.6	31.7
622	1,330	1,835	1,994
857	966	961	1,066
338	447	844	850
1,825	2,753	3,672	3,942
904	1,137	1,498	1,991
100	116	158	265
–	34.2	97.3	166
161	582	513	284
661	883	1,405	1,237
1,825	2,753	3,672	3,942

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
233	346	357	519
−509	−914	−750	−308
303	553	382	−220
27.4	−15.2	−11.4	−9.9
−158	−232	−321	−461
75.3	114	36.2	58.4
−0.4	−0.8	−0.8	−1.1

Shareholding pattern

Source: NSE filings

32.3%

promoters

Promoters32.33%
Public67.67%
As of 30 Sep 2026

Quarter	Promoters	Public	Promoter change
30 Sep 2026	32.33%	67.67%	minus 0.01
30 Jun 2026	32.34%	67.66%	minus 0.02
31 Mar 2026	32.36%	67.64%	minus 0.03
31 Dec 2025	32.39%	67.61%	minus 0.03
30 Sep 2025	32.42%	67.58%	–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you